About Human Biogenesis
Human Biogenesis is a company based in Guwahati (India) founded in 2020 by Debabrata Mandal and Sachitanand Roy. Human Biogenesis operates in a competitive market with competitors including Proov, Exseed Health, Sandstone Diagnostics, Spermosens and Bonraybio, among others.
- Headquarter Guwahati, India
- Founders Debabrata Mandal, Sachitanand Roy
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Human Biogenesis Private Limited
- Date of Incorporation 31 Jan, 2020
- Jurisdiction Katwa, West Bengal, India
-
Annual Revenue
$2.42 K (USD)0as on Mar 31, 2022
-
Net Profit
-$2.61 K (USD)-820.92as on Mar 31, 2022
-
EBITDA
-$5 K (USD)-1918.38as on Mar 31, 2022
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Human Biogenesis
Investors in Human Biogenesis
Human Biogenesis has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Campus Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Student-led startups are invested in by this venture capital firm.
|
Locked | Locked | Locked |
Investor details for Human Biogenesis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Human Biogenesis
Investment portfolio details for Human Biogenesis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Human Biogenesis
Detailed financials for Human Biogenesis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Human Biogenesis Comparisons
Peer comparison for Human Biogenesis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Human Biogenesis
Human Biogenesis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Proov, Exseed Health, Sandstone Diagnostics, Spermosens and Bonraybio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Progesterone-based fertility test kits are developed for conception detection.
|
|
| Locked | Locked | Locked |
Developer of a home-based sperm test kit
|
|
| Locked | Locked | Locked |
Provides rapid tests for accurate sperm count diagnostics.
|
|
| Locked | Locked | Locked |
Spermosens is focused on developing male-factor infertility diagnostic devices.
|
|
| Locked | Locked | Locked |
Bonraybio is focused on developing reproductive health solutions.
|
Detailed competitors of Human Biogenesis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Human Biogenesis
Complete news archive for Human Biogenesis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Human Biogenesis
Human Biogenesis was founded in 2020 and raised its 1st funding round 4 years after it was founded.
Human Biogenesis is headquartered in Guwahati, India. It is registered at Guwahati, Assam, India.
Debabrata Mandal is the current CEO of Human Biogenesis. They have also founded this company.
Annual revenue of Human Biogenesis is $2.42K as on Mar 31, 2022.
Human Biogenesis was founded in 2020 in Guwahati, India, within the reproductive health sector. Operations focus on womens health across pre-pregnancy, pregnancy, and post-pregnancy phases. Services encompass specialized gynecology, obstetrics, diagnostic testing, wellness programs, hygiene products, nutritional support, and digital tools. The SD Kit, a semen detection product, is included to address risks such as infertility and cancer.
Human Biogenesis's top competitors include Proov, Spermosens and Exseed Health.
Human Biogenesis has 1 investor. Key investors include Campus Fund.